Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

January 11, 2017 by Alan Khadavi

Eucrisa (crisaborole) New Eczema Medication gets FDA Approval

Eucrisa (crisaborole) recently won FDA approval for eczema (atopic dermatitis).  This would be the first non-steroidal skin therapy for eczema in 15 years, since Elidel and Protopic were approved.  Pfizer recently bought the rights to Eucrisa (crisaborole) back in May when it acquired its developer, Anacor, for 5.2 billion dollars.

There were 2 trials, consisting of over 1,500 patients with mild to moderate eczema, where Eucrisa (crisaborole) showed it was better than placebo in achieving clear or almost clear skin after 28 days of treatment.  The studies did not compare Eucrisa to any steroidal topical treatments.  Topical steroids are also used for eczema, but many patients do not like using them because of side effects such as thinning of the skin with long term usage.  Eucrisa (crisaborole) would be an alternative to use for mild to moderate patients with eczema.

Eucrisa (crisaborole) would be the first in its class of phosphodiesterase-4 (PDE4) inhibitors to treat eczema.  PDE4 inhibitors are already being used to treat inflammation for other disease conditions such as asthma, COPD and psoriasis.

Eucrisa (crisaborole) is expected to hit the market this year, the price will be approximately $580 for a 60 gram tube before any discounts or rebates.  There most certainly will be push back from insurance companies as a comparable tube for a topical steroid cream is only a few dollars.

Many new treatments are on the horizon for atopic dermatitis, as it affects millions of people worldwide.  The much anticipated drug, Dupixent (dupilumab) is expected to launch sometime this year and it is for more severe forms of eczema.

Dupilumab (Dupixent) for Atopic Dermatitis (Eczema) Sufferers

The most common side effects seen with Eucrica, were itching, burning and site pain.  Although crisaborole is a PDE4 inhibitor, the specific mechanism of action in eczema is unknown.

Because of its high cost, Eucrisa (crisaborole), patients will find it difficult to use it widespread on their bodies.  Most likely it will only be able to be used in patients who have small patches of eczema who do not want to use topical steroids.  Also it could be used in sensitive areas where you do not want to use topical steroids such as the face and genital regions.

An oral PDE4 inhibitor that functions in a mechanism similar to crisaborole, apremilast, is also being investigated for treatment of AD.

For more information on atopic dermatitis (eczema), speak to an allergy doctor or a dermatologist.  Here are some useful links below.

Atopic Dermatitis (Eczema) Treatment

Treatment of Atopic Dermatitis (Eczema)

Dupixent (Dupilumab) for Atopic Dermatitis/Eczema

Filed Under: atopic dermatitis, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

January 22, 2023

Is Benadryl Safe to use, or is it Time to Move on?

is benadryl safe

January 12, 2023

Airsupra for Asthma, a new rescue medication

airsupra

December 26, 2022

Cantaloupe Allergy comes in many flavors

cantaloupe allergy

December 23, 2022

Remibrutinib, a BTK inhibitor for Chronic Hives

remibrutininb

November 21, 2022

Eczema and Hard Water, is there a link?

eczema and hard water

November 19, 2022

Nucala, Fasenra or Dupixent for Severe Eosinophilic Asthma?

nucala fasenra dupixent

November 18, 2022

Xolair for idiopathic angioedema

xolair for idiopathic angioedema

September 29, 2022

When will my child outgrow egg allergy?

outgrow egg allergy

September 13, 2022

Can you be allergic to water? (Aquagenic Urticaria)

allergic to water

September 8, 2022

Oclacitinib for Atopic Dermatitis (Eczema) in Dogs

oclacitinib

Read More Posts...

Follow Us…

© 2023 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page